Search

The incidence of mouth and throat cancer is on the rise due to oral transmission of the human papilloma virus, but the "silver lining" of this phenomenon is doctors at Memorial Sloan Kettering have significantly reduced the intensity of treatment while achieving excellent outcomes for these patients.

… Wednesday, February 15, 2017 The incidence of mouth and throat cancer is on the rise due to transmission of the human papilloma virus (HPV), but the “silver lining” of this phenomenon is doctors at Memorial Sloan Kettering (MSK) can significantly reduce the intensity of treatment and improve quality

The updated dietary guidelines from the federal government have caused confusion, but MSK dietitians' recommendations have not changed: A diet that is mostly plant based is still considered the most healthy.

… Wednesday, March 11, 2026 VIDEO | 01:16 MSK Explains: The New Food Pyramid MSK registered dietitian-nutritionist Christina Stella helps break down how to interpret the latest U.S. federal dietary guidelines. Video Details If you’ve heard about the new federal dietary guidelines and feel a little confused

In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with us for initial or ongoing cancer care.

… Wednesday, September 21, 2016 In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center (MSK) has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.

… Thursday, July 1, 2010 Summary Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute. Harold

There is a clear and unmet need for less invasive and more accurate methods for diagnosing lung cancer. A promising innovation under investigation at Memorial Sloan Kettering Cancer Center (MSK) is the electronic nose (e-nose), which evaluates volatile organic compounds (VOCs) in exhaled breath. The e-nose platform detects a lung cancer-associated “breathprint” in breath from individuals with lung cancer.

… Friday, September 15, 2023 There is a clear and unmet need for less invasive and more accurate methods for diagnosing lung cancer. A promising innovation under investigation at Memorial Sloan Kettering Cancer Center (MSK) is the electronic nose (e-nose), which evaluates volatile organic compounds (VOCs

MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs.

… Monday, February 22, 2021 Summary The level of genetic mutations in a tumor, called tumor mutational burden (TMB), has been used to predict how people with cancer will respond to immunotherapy. But MSK physician-scientist Luc Morris explains that important aspects of TMB’s clinical relevance have needed

Find out why you still need your routine mammogram, even during COVID-19.

… Wednesday, October 6, 2021 At a time when too many women delayed their yearly mammogram because of the pandemic, Katie Gay is very glad she did not miss hers. She knew that because of her dense breasts, regular screenings were critical. After her routine mammogram in February 2021, Katie found out she

Learn about Madeleine Ruff’s inspiring story, from being treated at MSK Kids for a rare cancer as a teenager to managing clinical trials for new cancer treatments as an adult.

… Monday, June 10, 2024 Madeleine Ruff, MHA, helps manage  clinical trials that test new cancer treatments to see how well they work. It’s an important job but one that doesn’t seem all that unusual, until you learn that Maddy started her career as a professional rock ’n’ roll and jazz singer. It’s certainly

Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults.

… Monday, January 30, 2023 Based a clinical trial conducted at MSK, the FDA has approved the targeted drug cobimetinib (Cotellic®) for treating a rare group of diseases known as histiocytoses, or histiocytic neoplasms in adults. For years, Robin Bankins had chronic sinus pain — one of the effects of Rosai-Dorfman

Human papillomavirus (HPV)–associated oropharyngeal cancer is on the rise, but at Memorial Sloan Kettering Cancer Center, we have updated our standard of care to substantially reduce the radiation dose to elective regions.

… Tuesday, December 10, 2019 Human papillomavirus (HPV)–associated oropharyngeal cancer is on the rise, but at Memorial Sloan Kettering Cancer Center, we have updated our standard of care to substantially reduce the radiation dose to elective regions. In our paper, published recently in the journal Practical